Comerica Bank Sage Therapeutics, Inc. Transaction History

Comerica Bank

$23.4 Billion
Q1 2025

A detailed history of Comerica Bank transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Comerica Bank holds 120 shares of SAGE stock, worth $783. This represents 0.0% of its overall portfolio holdings.

Number of Shares

120

Previous 120 -0.0%

Holding current value

$783

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.78 - $8.57 $535 - $959	112 Added 1400.0%	120 $0
Q3 2024 Nov 14, 2024	SELL	$7.02 - $13.08 $161 - $300	-23 Reduced 74.19%	8 $0
Q2 2024 Aug 15, 2024	SELL	$10.58 - $17.9 $3,121 - $5,280	-295 Reduced 90.49%	31 $0
Q1 2024 May 15, 2024	SELL	$18.62 - $26.95 $186 - $269	-10 Reduced 2.98%	326 $6,000
Q4 2023 Feb 14, 2024	BUY	$17.1 - $22.26 $4,599 - $5,987	269 Added 401.49%	336 $7,000
Q3 2023 Nov 21, 2023	BUY	$16.75 - $48.98 $1,122 - $3,281	67 New	67 $1,000
Q1 2021 Apr 28, 2021	SELL	$70.65 - $96.76 $2.08 Million - $2.85 Million	-29,469 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$58.41 - $89.06 $474,814 - $723,968	8,129 Added 38.09%	29,469 $2.55 Million
Q3 2020 Oct 30, 2020	BUY	$41.13 - $62.45 $208,611 - $316,746	5,072 Added 31.18%	21,340 $1.3 Million
Q2 2020 Jul 31, 2020	BUY	$25.95 - $43.15 $40,092 - $66,666	1,545 Added 10.49%	16,268 $676,000
Q1 2020 May 01, 2020	BUY	$26.15 - $77.24 $124,552 - $367,894	4,763 Added 47.82%	14,723 $422,000
Q4 2019 Feb 07, 2020	BUY	$60.18 - $154.77 $143,228 - $368,352	2,380 Added 31.4%	9,960 $719,000
Q3 2019 Oct 31, 2019	BUY	$140.29 - $189.96 $798,951 - $1.08 Million	5,695 Added 302.12%	7,580 $1.06 Million
Q2 2019 Aug 02, 2019	BUY	$157.85 - $183.09 $40,883 - $47,420	259 Added 15.93%	1,885 $0
Q1 2019 May 02, 2019	BUY	$89.33 - $163.65 $145,250 - $266,094	1,626 New	1,626 $0
Q4 2018 Feb 06, 2019	SELL	$81.94 - $139.71 $133,726 - $228,006	-1,632 Closed	0 $0
Q3 2018 Nov 01, 2018	SELL	$138.11 - $169.04 $4,833 - $5,916	-35 Reduced 2.1%	1,632 $200,000
Q2 2018 Aug 01, 2018	BUY	$140.36 - $175.76 $29,615 - $37,085	211 Added 14.49%	1,667 $282,000
Q1 2018 May 01, 2018	BUY	$152.15 - $192.33 $17,192 - $21,733	113 Added 8.41%	1,456 $247,000
Q4 2017 Feb 02, 2018	BUY	$60.72 - $167.34 $81,546 - $224,737	1,343	1,343 $242,000

Others Institutions Holding SAGE

# of Institutions

217

Shares Held

49.9M

Call Options Held

220K

Put Options Held

312K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $388M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account